drugset / Trial / NCT01006018

DPP-4 Inhibition and TZD for DM Prevention

NCT01006018

RandomizedParallel-groupQuadruple-blindPrevention

Summary

To determine whether treatment with the diabetes medication, Januvia (sitagliptin), with or without another diabetes medicine, Actos (pioglitazone), will improve insulin secretion and insulin response individuals with Impaired Glucose Tolerance (IGT), a form of prediabetes.

Timeline

Start
2011-07
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule 15 mg Oral
Subject Sitagliptin Small molecule 100 mg Oral

Indications